Malignant neoplasm, pancreas
Disease

Medical Tests (30)
Screening/Initial Testing (6)
Diagnostic Testing (11)
Hepatic Function Panel (Liver Panel)
8
Note:

Some component of this panel might be part of the comprehensive metabolic panel.

Insulin, Random
7
Note:

Rule out cancer of islet cells.

Epidermal Growth Factor Receptor (EGFR) Gene Mutation Analysis
5
Note:

EGFR is expressed 30-50% in Pancreatic ductal adenocarcinoma (PDAC). http://www.ncbi.nlm.nih.gov/pubmed/26361407

KRAS Gene Mutation Analysis
5
Note:

Not specific for pancreas cancer, but helpful in therapy treatment.

Disease Management Testing (4)
Other Supportive/Alternative Tests (9)
Cytochrome P450 2A6 (CYP2A6) Genotyping
6
Note:

Determine therapeutic strategy for cancer therapeutics such as Tegafur.

Solid Tumor Gene Mutation Panel
5
Note:

Alternative to specif gene markers. Good for therapy selection and monitoring.

Cancer Antigen Profile
4
Note:

Individual cancer test tissue specific is recommended.

ICD10
C25Malignant neoplasm of pancreas
C25.0Malignant neoplasm of head of pancreas
C25.1Malignant neoplasm of body of pancreas
C25.2Malignant neoplasm of tail of pancreas
C25.7Malignant neoplasm of other parts of pancreas
C25.9Malignant neoplasm of pancreas, unspecified
Z85Personal history of malignant neoplasm
Z85.07Personal history of malignant neoplasm of pancreas

Additional ICD10
C25.0Malignant neoplasm of head of pancreas
C25.1Malignant neoplasm of body of pancreas
C25.2Malignant neoplasm of tail of pancreas
C25.3Malignant neoplasm of pancreatic duct
C25.4Malignant neoplasm of endocrine pancreas
C25.7Malignant neoplasm of other parts of pancreas
C25.8Malignant neoplasm of overlapping sites of pancreas
C25.9Malignant neoplasm of pancreas, unspecified
D13.6Benign neoplasm of pancreas
Z85.07Personal history of malignant neoplasm of pancreas

SNOMED
372003004Primary malignant neoplasm of pancreas